Everything we're saying.
And being said about us.
news
PAICON Featured in FOUND - Startup Magazine Heidelberg
PAICON has been featured in FOUND – Startup Magazin Heidelberg, where our mission, innovations, and flagship AI solutions like SatSight DX are highlighted as drivers of...
news
The Remaining84 in Real Life: A Common Cancer Drug Took Her Life Instead of Saving
A 60-year-old woman’s tragic reaction to a common cancer drug exposes the Remaining84 problem: the 84% of the world’s population underrepresented in genomic data. At PAICON,...
news
Global Collaboration Needed for AI in Oncology
AI in oncology cannot succeed without global collaboration. The Remaining84 problem highlights how most cancer datasets come from just 16% of the world’s population. PAICON is...
news
Explainable AI in Pathology: Building Trust in Clinical Diagnostics
Explainable AI (XAI) is bridging the gap between powerful cancer diagnostics and clinical trust. By making predictions transparent and interpretable, XAI empowers pathologists and clinicians to...
news
Foundation Models in Computational Pathology: Opportunities & Hurdles
Foundation models are transforming computational pathology with more accurate, adaptable cancer diagnostics. At PAICON, we see them as key to making oncology AI more inclusive, reliable,...
news
The Remaining84 in Real Life: Killed by a Chemotherapy Meant to Save Him
When Dr. Anil Kapoor, a respected urologist and head of transplants at St. Joseph's Healthcare in Hamilton, Ontario, was diagnosed with stage four colon cancer in...
news
Can AI Learn the Dialect of Histology?
Histology is more than what meets the eye; it's a complex language. Now, artificial intelligence is beginning to understand its syntax.
news
The Hidden Hero Behind Cancer AI: Clean Data
AI is rapidly becoming a key technology in cancer diagnostics, especially in digital pathology.
news
Why Black-Box AI Doesn't Work in Cancer Care and What the Future Looks Like Instead
AI is accelerating progress in cancer care, from improving early detection to helping tailor treatments with greater precision. But one major challenge still stands in the...